.INVESTIGATION EMPHASIZE.16 October 2024. In the NIAGARA hearing, the add-on of perioperative durvalumab to standard procedure for muscle-invasive bladder cancer improved event-free and also in general survival, noting a brand new therapy option for this disorder.